The Pharmaceutical Journal
Vol 274 No 7340 p291
12 March 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Atherothrombosis undertreated

Atherothrombosis is undertreated worldwide, data presented at the American College of Cardiology meeting this week suggest. The results are based on observations of more than 60,000 patients in 43 countries from the REACH (reduction of atherothrombosis for continued health) study and show that despite progress in the treatment and management of atherothrombosis, at-risk patients are still insufficiently managed.